Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Just like that stupid fight you dont remember who started and why
All doses of tirzepatide and semaglutide increased the risk for gastrointestinal adverse events versus placebo, with tirzepatide 15 mg yielding the highest risk for nausea (risk ratio [RR], 3.57), vomiting (RR, 4.35), and diarrhea (RR, 2.04)
The patient, who had type 2 diabetes mellitus and was already on metformin, began experiencing progressive vomiting after meals over several months, along with significant unintentional weight loss
Many women report reduced anxiety and improved mood after starting treatment, partly from the weight loss itself and partly from the direct neurological effects of GLP-1 receptor activation on mood-regulating brain circuits
Ultimately, careful monitoring, patient education, and individualized treatment plans are key
